Stay updated on Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page
- Check4 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2 and the Back to Top element was removed; no other core content, pricing, stock, or time-slot information appears to have changed.SummaryDifference0.5%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.SummaryDifference62%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1: Clinical Trial page.